Drug Cos. Try To Keep Cephalon Case Info Under Wraps
A slew of drug companies are seeking to intervene in the Federal Trade Commission's antitrust suit alleging Cephalon Inc. paid off generics competitors in a reverse payment agreement over the patent...To view the full article, register now.
Already a subscriber? Click here to view full article